A research brief that shows its sources, not just its conclusions.
Give MedSolve Labs a disease name and it returns a structured brief — overview, mechanisms, standard of care — built from live literature and database queries, with every claim traced to a PMID, an Open Targets entry, or a UniProt record. When two sources disagree, it says so instead of picking one quietly.
Professional research use only. MedSolve Labs synthesizes research literature. It does not provide medical advice and must not be used for diagnosis or treatment. The brief above is a real, live-generated example; disease names and citation IDs are real, not staged.
The anatomy of one brief
A generated paragraph is only as trustworthy as what it's built from. Every section of a MedSolve Labs brief carries its own consistency check, separate from the brief's overall accuracy score.
Beyond a single disease brief
The disease brief is the most visible surface, but the same grounding discipline runs through the rest of the lab — from target identification to a structured look at why a past trial didn't work.
Targets
CoreGene and protein targets implicated in a disease, with the association evidence behind each one.
Organisms
Reference dataModel-organism data relevant to a target or pathway, alongside the human evidence.
Molecules
Reference dataCompound-level data tied to a target, for the molecules already implicated in it.
Trial Failure Autopsy
AnalysisA structured breakdown of why a past clinical trial failed, not just the fact that it did.
Audit
GroundingThe accuracy log behind every generated brief, reviewable rather than taken on faith.
Follow-up questions, same rule
A brief raises follow-up questions. The session Q&A answers them — constrained strictly to the references already cited in the brief, rather than reaching for outside knowledge.
"What's the evidence behind the receptor-targeting mechanism?"
Per UniProt:P12345, structural mapping shows abnormal folding and active-site mutations altering receptor binding — consistent with the pathway association in OT:ENSG00000130600. Both sources agree on the mechanism; the open question is patient-specific efficacy, which is why Standard of Care carries the issue flag above.
Demo · a fixed example question and answer, shown to illustrate the constraint — not a live model call.
What this is, and what it isn't
MedSolve Labs is MANU's own research-lab initiative, separate from the RealActivity collaboration — a place to test ideas that might later become their own project, not a single fixed product.
Core Disease Intelligence v1.0
Disease-brief generation against live literature and database queries, with inline citations, per-section consistency checks, and a grounding audit — built, and currently under review before merging into the main line.
- PMID, Open Targets, and UniProt citations, live
- Multi-source consistency checks per section
- Trial Failure Autopsy and grounding audit
Not a diagnostic or treatment tool
MedSolve Labs synthesizes research literature for professional research use. It is not medical advice, not a diagnostic device, and every output needs expert review before it informs a real decision.
- No fixed roadmap — ideas here may spin out or be dropped
- Not tied to a single deliverable, unlike MANU's other projects
Interested in this project?
MedSolve Labs is the most open-ended of MANU's current projects — a good one to talk about if you have a research workflow it might fit.
Talk to us about MedSolve Labs
Or ask what v1.0's review is currently focused on.